Peter Attia· MD
right now the way I read it is people are willing to invest modestly in molecules that are rapy and derivative derivatives G they still though have the mindset mtor is drugged and therefore if you want to go to other components of the pathway which I think we don't have time to discuss them would be more interesting there's really not an appetite for that